Avalo Therapeutics (AVTX) Net Margin Growth (1y) (2017 - 2025)
Avalo Therapeutics (AVTX) Net Margin Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Avalo Therapeutics |
295.77 Mn |
295.77 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-484,851.00 |
| Dec 31, 2024 |
-1.70 Mn |
| Sep 30, 2024 |
1.15 Mn |
| Dec 31, 2021 |
-6,301.00 |
| Sep 30, 2021 |
2,345.00 |
| Jun 30, 2021 |
3,606.00 |
| Mar 31, 2021 |
-6,010.00 |
| Dec 31, 2020 |
-121,575.00 |
| Sep 30, 2020 |
3,151.00 |
| Jun 30, 2020 |
23,029.00 |
| Mar 31, 2020 |
12,664.00 |
| Dec 31, 2019 |
123,672.00 |
| Sep 30, 2019 |
55,447.00 |
| Jun 30, 2019 |
-13,876.00 |
| Mar 31, 2019 |
-234.00 |
| Dec 31, 2018 |
17,414.00 |
| Sep 30, 2018 |
-67,857.00 |
| Jun 30, 2018 |
101,420.00 |
| Mar 31, 2018 |
42,370.00 |
| Dec 31, 2017 |
73,861.00 |
